News & Updates

Treatment with seladelpar significantly improves serum markers of cholestasis, including alkaline phosphatase (ALP) and total bilirubin (TB), and reduces pruritus in patients with primary biliary cholangitis (PBC) who are at risk for disease progression, according to the RESPONSE trial presented at The Liver Meeting 2023.

Treatment with flexible ureteroscopy (FE) results in a significantly higher stone-free rate than shock wave lithotripsy (SWL) in children with renal stones, reports a study. No difference is seen in complication rate or fluoroscopy exposure time between groups, but operative times and hospital stay are longer with FU.

Most patients prefer same-day discharge (SDD) over inpatient robotic-assisted radical prostatectomy (RARP) because of its cost-effectiveness, reports a study. The SDD approach maintains similar satisfaction levels and has comparable rates of complications across institutions and differing surgeon experience.

Higher baseline and 1-year increases in N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels among individuals receiving blood pressure (BP)-lowering medications are associated with subsequent declines in estimated glomerular filtration rate (eGFR), according to a study.

Treatment with dupilumab reduces the use of systemic corticosteroids (SCS) in children with moderate-to-severe asthma, regardless of exacerbation history, according to a post hoc analysis of the VOYAGE and EXCURSION trials presented at APSR 2023.